Eilon Kirson
2017
In 2017, Eilon Kirson earned a total compensation of $2.8M as Chief Science Officer and Head of R&D at NovoCure, a 174% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $286,075 |
|---|---|
| Option Awards | $1,116,133 |
| Salary | $455,284 |
| Stock Awards | $780,780 |
| Other | $204,319 |
| Total | $2,842,591 |
Kirson received $1.1M in option awards, accounting for 39% of the total pay in 2017.
Kirson also received $286.1K in non-equity incentive plan, $455.3K in salary, $780.8K in stock awards and $204.3K in other compensation.
Rankings
In 2017, Eilon Kirson's compensation ranked 3,841st out of 14,666 executives tracked by ExecPay. In other words, Kirson earned more than 73.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,841 out of 14,666 | 74th |
Division Manufacturing | 1,342 out of 5,768 | 77th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 180 out of 856 | 79th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 102 out of 528 | 81st |
Industry Surgical and Medical Instruments and Apparatus | 62 out of 333 | 81st |
Source: SEC filing on April 20, 2018.
Kirson's colleagues
We found four more compensation records of executives who worked with Eilon Kirson at NovoCure in 2017.